David K. Gaffney,
MD, PhD, FACR, FABS, FASTRO
Vice-Chair, Department of Radiation Oncology
Languages Spoken: English
Senior Director for Clinical Research, Huntsman Cancer Institute
Professor, Department of Radiation Oncology, University of Utah
J Robert and Ann K Stewart Endowed Professorship
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
Clinical Locations
801-581-2396
Fax: (801) 585-2666
Specialties
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.8/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 21, 2022
HUNTSMAN CANCER CENTER
I've never felt more confidence in my choice of care!
UofU Patient
January 24, 2022
SUGAR HOUSE HEALTH CENTER
I appreciate Dr. Gaffney's gentle and encouraging manner.
UofU Patient
December 25, 2021
HUNTSMAN CANCER CENTER
Deeply grateful for the empathetic and personalized care the Dr. Gaffney gives me visit after visit.
UofU Patient
December 06, 2021
HUNTSMAN CANCER CENTER
Scheduled an appointment for me but did not explain what the appointment is for. Read portal I think I am having c scan or MRI. This was not explained. Doctor would look at e and talk, then look at himself in the mirror and keep talking to his reflections
UofU Patient
November 14, 2021
HUNTSMAN CANCER CENTER
Doctor, nurse and resident Dr were all fantastic
UofU Patient
September 20, 2021
HUNTSMAN CANCER CENTER
The rarity of this cancer has left us with many unknown and unanswered questions about the treatment. The best options are being considered.
UofU Patient
July 26, 2021
HUNTSMAN CANCER CENTER
The student (Adam) and the resident (Dr. Wiel) that accompanied Dr. Gaffney were very professional. Dr. Gaffney however, was not and he made comments about my body that made me feel like a freak of nature and ultimately lead to me having a panic attack in the parking garage.
UofU Patient
July 22, 2021
HUNTSMAN CANCER CENTER
I wish I had known more about the treatment before I got there because I didn't know what questions to ask about radiation therapy.
UofU Patient
July 18, 2021
HUNTSMAN CANCER CENTER
Dr. Gaffney's consultation was thorough and relevant in helping me understand the procedure and possible side effects. He made me feel comfortable asking questions, and his responses were informative and to the point.
UofU Patient
July 07, 2021
HUNTSMAN CANCER CENTER
Excellent
UofU Patient
July 07, 2021
HUNTSMAN CANCER CENTER
Efficiently completed set up to keep procedure moving
UofU Patient
June 06, 2021
HUNTSMAN CANCER CENTER
I felt very cared for, made a top priority, and was in such capable hands with every single aspect of my care there. Amazing!
UofU Patient
April 20, 2021
HUNTSMAN CANCER CENTER
Too many STUDIES! Made the process overwhelming.
UofU Patient
April 19, 2021
HUNTSMAN CANCER CENTER
Even though I don't "need" radiation therapy the providers PA and MD both understood my desire to move forward with it as a preventive/deterrent to lower my risk of return of cancer.
UofU Patient
February 26, 2021
HUNTSMAN CANCER CENTER
I have been very impressed with the care I have received
UofU Patient
December 22, 2020
HUNTSMAN CANCER CENTER
I was treated very well and the treatment was well explained to me. My questions were answered clearly so I had no worries.
UofU Patient
December 21, 2020
HUNTSMAN CANCER CENTER
This was a most positive and patient supportive virtual meeting. Dr.G was a most positive provider allowing this client to weigh follow up procedures with a more substantive base of info. Very Grateful to this physician.
UofU Patient
December 06, 2020
HUNTSMAN CANCER CENTER
extremely good
UofU Patient
October 22, 2020
HUNTSMAN CANCER CENTER
The doctor did a good job of going over my options and the statistics/research given those various options. There seemed to be a little less concern for the risks but I try to remember that most doctors have not actually been through the procedure themselves, so really don't know other than what others may have said they experienced.
UofU Patient
October 05, 2020
HUNTSMAN CANCER CENTER
Dr. Gaffney and Dr. Gruhl rule! :)
UofU Patient
September 08, 2020
HUNTSMAN CANCER CENTER
love dr Gaffney
UofU Patient
August 16, 2020
HUNTSMAN CANCER CENTER
Good
UofU Patient
August 11, 2020
HUNTSMAN CANCER CENTER
I felt he rushed through this appt where I didn't fully understand my schedule of treatment plan
UofU Patient
July 27, 2020
HUNTSMAN CANCER CENTER
I like that Dr. Gaffney treats me like an equal. it's so refreshing!!
UofU Patient
July 20, 2020
HUNTSMAN CANCER CENTER
Dr Gaffney is the BEST!! he was very patient, informative and answered my questions!!!
UofU Patient
May 23, 2020
HUNTSMAN CANCER CENTER
When you are a cancer patient you always wonder about the return of your CANCER. Dr Gaffney calmed me down before I left. I needed that.
Senior Director for Clinical Research, Huntsman Cancer Institute
Professor, Department of Radiation Oncology, University of Utah
J Robert and Ann K Stewart Endowed Professorship
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
Research Interests
- Gynecologic Oncology
- Breast Cancer
- Lymphoma
- Secondary Cancer Risk
- Prognostic Markers
- Clinical Trial Development
Education History
| Residency | University of Utah Radiation Oncology Resident, 1996 |
| Internship | LDS Hospital Intern, 1993 |
| Professional Medical | Medical College of Wisconsin Medicine M.D., 1992 |
| Doctoral Training | Medical College of Wisconsin Biochemistry Ph.D., 1990 |
| Undergraduate | University of Colorado Chemistry B.A., 1984 |
Selected Publications - Journal Articles
Journal Article
- Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241.
- Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD (2021). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw, 19(8), 888-895.
- Holcombe RF, Verschraegen CF, Chapman AE, Gaffney D, Goldberg RM, Mesa RA, Milhem M, Mims M, Mitchell EP, Mulkerin D, Vijayakumar S (2021). Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care. J Natl Compr Canc Netw, 19(2), 122-125.
- Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK (2020). NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys, 109(2), 413-424.
- Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol, 7, 173-182.
- Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao R (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med, 9(21), 7954-7963.
- Small W Jr, Peltecu G, Puiu A, Corha A, Cocr E, Cigran RG, Plante M, Jhingran A, Stang K, Gaffney D, Bacon M, McCormack M (2020). Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference. Int J Gynecol Cancer, 31, 1061-1067.
- Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W Jr (2020). Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecol Oncol, 158(2), 460-466.
- Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan AN (2020). Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecol Oncol, 158(2), 244-253.
- Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410.
- Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter AD (2020). NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw, 18(6), 660-666.
- Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA (2020). Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. J Clin Oncol, 38(15), 1685-1692.
- Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250.
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92.
- Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2019). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42.
- Kim S, Park J, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Deshmukh VG, Newman M, Herget K, Porucznik CA, Ose D, Playdon M, Gaffney D, Hashibe M (2019). Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Gynecol Oncol, 156(1), 185-193.
- Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava M (2020). American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. Brachytherapy, 19(2), 127-138.
- Zhao H, Williams N, Poppe M, Sarkar V, Wang B, Rassiah-Szegedi P, Huang YJ, Kokeny K, Gaffney D, Salter B (2019). Comparison of surface guidance and target matching for image-guided accelerated partial breast irradiation (APBI). Med Phys, 46(11), 4717-4724.
- Boothe D, Orton A, Kim J, Poppe MM, Werner TL, Gaffney DK (2019). Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer? Am J Clin Oncol, 42(11), 813-817.
- Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J (2019). Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(11), 1374-1391.
- Blackburn BE, Soisson S, Rowe K, Snyder J, Fraser A, Deshmukh V, Newman M, Smith K, Herget K, Kirchhoff AC, Kepka D, Werner TL, Gaffney D, Mooney K, Hashibe M (2019). Prognostic factors for rural endometrial cancer patients in a population-based cohort. BMC Public Health, 19(1), 921.
- Francis SR, Ager BJ, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK (2019). Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy. Gynecol Oncol, 154(1), 38-44.
- Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW (2019). Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol, 154(1), 183-188.
- Boothe D, Wolfson A, Christensen M, Francis S, Werner TL, Gaffney DK (2019). Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use. Am J Clin Oncol, 42(7), 549-554.
- Berek JS, Matsuo K, Grubbs BH, Gaffney DK, Lee SI, Kilcoyne A, Cheon GJ, Yoo CW, Li L, Shao Y, Chen T, Kim M, Mikami M (2019). Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. J Gynecol Oncol, 30(2), e40.
- Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK (2019). Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer? Brachytherapy, 18(4), 453-461.
- Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2019). Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(1), 64-84.
- Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Al-Sarray A, Werner TL, Setiawan VW, Hashibe M (2018). Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. J Natl Cancer Inst, 110(12), 1342-1351.
- Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554.
- Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman JM (2018). Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy. J Gastrointest Oncol, 9(6), 1044-1053.
- Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2018). Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol, 36(24), 2538-2544.
- Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK (2018). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. Am J Clin Oncol, 41(8), 784-791.
- Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W Jr (2018). Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. Int J Radiat Oncol Biol Phys, 101(5), 1069-1077.
- Olpin J, Chuang L, Berek J, Gaffney D (2018). Imaging and cancer of the cervix in low- and middle-income countries. Gynecol Oncol Rep, 25, 115-121.
- Ager BJ, Gallardo-Rincn D, de Len DC, Chvez-Blanco A, Chuang L, Dueas-Gonzlez A, Gmez-Garca E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Prez-Plasencia C, Plante M, Poveda A, Gaffney DK (2018). Advancing clinical research globally: Cervical cancer research network from Mexico. Gynecol Oncol Rep, 25, 90-93.
- Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol, 28(6), 377-384.
- Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Werner TL, Setiawan VW, Hashibe M (2018). Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol, 148(3), 499-506.
- Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2018). Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 16(2), 170-199.
- Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe MM (2017). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. Breast J, 24(1), 7-11.
- Huang YJ, Su FF, Gaffney DK, Kokeny KE, Zhao H, Rassiah-Szegedi P, Salter BJ, Poppe MM (2018). Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy, 17(6), 956-965.
- Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk, 17(12), 819-824.
- Torgeson A, Boothe D, Poppe MM, Suneja G, Gaffney DK (2017). Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecol Oncol, 147(2), 320-328.
- Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast, 35, 122-129.
- Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK (Sept. 2017 ePub ahead of press). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk.
- Frandsen J, Cannon G, Kokeny KE, Gaffney DK, Wright M, Pena K, Poppe MM (2017). Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review. Breast J, 23(4), 452-455.
- Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK (2017). Cervical cancer: A global health crisis. Cancer, 123(13), 2404-2412.
- Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty BG (2017). Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. J Clin Oncol, 35(18), 2037-2043.
- Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W (2016). Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys, 95(4), 1191-200.
- Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D (2016). Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol, 141(3), 501-506.
- Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney DK (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecol Oncol, 141(3), 421-427.
- Sharma DN, Gaffney DK (2016). Concurrent chemobrachytherapy in locally advanced cervical carcinoma: A hypothesis worth exploring. Brachytherapy, 15(2), 200-4.
- Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe MM (2016). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Med Dosim, 41(3), 195-8.
- Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe MM (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Int J Radiat Oncol Biol Phys, 93(5), 1096-103.
- Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr (2015). ACR Appropriateness Criteria(R) Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park), 29(11), 867-72, 874-5.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL, National Comprehensive Cancer Network (2015). Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 13(11), 1321-31.
- Lim K, Erickson B, Jrgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A (2015). Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol, 5(6), e557-65.
- Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd S (2015). Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol, 6(5), 516-23.
- Ly D, Soisson PA, Dodson MK, Sause WT, Gaffney DK (2015). Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology. Gynecol Oncol, 138(3), 526-31.
- Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A (2015). Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy, 14(5), 587-99.
- Gaffney DK, Suneja G, Ryu SY, McCormick M, Plante M, Mileshkin L, Small W Jr, Bacon M, Stuart G, Kitchener H (2015). The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. Int J Radiat Oncol Biol Phys, 92(3), 506-8.
- Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK (2015). NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer, 121(13), 2156-63.
- Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, Dodson MK, Werner T, Gaffney DK (2015). Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer. Am J Clin Oncol, 38(3), 283-8.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR 3rd, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL (2015). Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw, 13(4), 395-404; quiz 404.
- Williams NL, Werner TL, Jarboe EA, Gaffney DK (2015). Adenocarcinoma of the cervix: should we treat it differently? Curr Oncol Rep, 17(4), 17.
- Nickman NA, Ye X, Gaffney DK, Barney RB, Biskupiak JE, Okano GJ, Lee VC, Arellano J (2015). Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer. 13(3), 95-103.
- Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney DK (2015). Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol, 136(3), 521-8.
- Suneja G, Bacon M, Small W Jr, Ryu SY, Kitchener HC, Gaffney DK (2015). The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries. Front Oncol, 5, 14.
- Bagshaw HP, Pappas LM, Kepka DL, Tward JD, Gaffney DK (2014). Patterns of care with brachytherapy for cervical cancer. Int J Gynecol Cancer, 24(9), 1659-64.
- Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, DSouza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W (2014). Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, 90(2), 320-8.
- Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK (2014). ACR appropriateness Criteria(R) advanced stage endometrial cancer. Am J Clin Oncol, 37(4), 391-6.
- Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W Jr (2014). Radiation therapy oncology group gynecologic oncology working group: comprehensive results. Int J Gynecol Cancer, 24(5), 956-62.
- Ly D, Rowley BD, Dodson MK, Soisson PA, Jolles CJ, Gaffney DK, Sause WT (2014). Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival. Gynecol Oncol, 133(2), 250-5.
- Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas J (2014). The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One, 9(4), e94167.
- Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2014). Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol, 37(2), 131-4.
- Frandsen JE, Sause WT, Dodson MK, Soisson AP, Belnap TW, Gaffney DK (2014). Survival analysis of endometrial cancer patients with cervical stromal involvement. J Gynecol Oncol, 25(2), 105-10.
- Lalwani N, Dubinsky T, Javitt MC, Gaffney DK, Glanc P, Elshaikh MA, Kim YB, Lee LJ, Pannu HK, Royal HD, Shipp TD, Siegel CL, Simpson L, Wahl AO, Wolfson AH, Zelop CM, American College of Radiology (2014). ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q, 30(1), 21-8.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR 3rd, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes M (2014). Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw, 12(2), 248-80.
- Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D (2014). RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Int J Radiat Oncol Biol Phys, 88(1), 101-5.
- Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Jant-Amsbury MM (2013). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. Int J Pharm, 458(1), 148-55.
- Wagner AE, Wada D, Bowen G, Gaffney DK (2013). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. . Br J Dermatol, 169(3), 715-8.
- Anker CJ, ODonnell K, Boucher KM, Gaffney DK (2013). Effect of brachytherapy technique and patient characteristics on cervical cancer implant dosimetry. . Med Dosim, 38(4), 430-5.
- Gay HA, Barthold HJ, OMeara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM (2012). Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys, 83(3), e353-62.
- Cooke EW, Pappas L, Gaffney DK (2011). Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer, 117(18), 4231-7.
- Lim K, Small W Jr, Portelance L, Creutzberg C, Jrgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys, 79(2), 348-55.
- Ghia AJ, Neeley ES, Gaffney DK (2010). Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer. Gynecol Oncol, 119(3), 411-6.
- Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney D (2009). Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128. Clin Cancer Res, 15(12), 4199-206.
- Petru E, Lck HJ, Stuart G, Gaffney D, Millan D, Vergote I (2009). Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol, 143(2), 69-74.
- Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12(1), 250-6.
- Lee CM, Salzman KL, Blumenthal DT, Gaffney DK (2005). Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy. Am J Hematol, 78(2), 151-2.
- Patton GA, Gaffney DK, Moeller JH (2003). Facilitation of radiotherapeutic error by computerized record and verify systems. Int J Radiat Oncol Biol Phys, 56(1), 50-7.
Review
- McCormack M, Gaffney D, Tan D, Bennet K, Chavez-Blanco A, Plante M (2021). The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries. [Review]. Int J Gynecol Cancer, 31(5), 775-778.
- Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK (2013). Acr appropriateness Criteria management of vaginal cancer. [Review]. Oncology (Williston Park), 27(11), 1166-73.
- Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR (2013). ACR Appropriateness Criteria(R) management of locoregionally advanced squamous cell carcinoma of the vulva. [Review]. Am J Clin Oncol, 36(4), 415-22.
Book
- David K Gaffney, Dennis C Shrieve, Christopher J Anker, Mark K Buyyounouski, Feng-Ming Kong, Ying J Hitchcock, Jonathan D Tward (12/2012). Radiation Oncology: Imaging and Treatment. Amirsys.
Book Chapter
- Boothe D, Gaffney DK (2016). Radiotherapy for Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul: Gunes Publishing.
- Orton AW, Gaffney DK (2016). Radiotherapy for Vaginal Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.). (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul:: Gunes Publishing.
- Jonathan D Tward, Christopher J Anker, David K Gaffney and Glen M Bowen (March 2012). Radiation Therapy and Skin Cancer. In Modern Practices in Radiation Therapy.
- Ghia A, Gaffney DK (2011). Radiotherapy for Vaginal and Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (First). Istanbul: Gunes Publishing.
- Mayer NA, Gaffney DK, Small Q (May 2011). Cervical Cancer (Ch. 22). In Liu JL, Brady LW (Eds.), Decision Making in Radiation Oncology (pp. 662-701). Springer.
- Anker CA, Gaffney DK (2011). Ovary. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 365-384). Philadelphia: Lippencott Williams and Wilkins.
- Gonzalez VJ, Gaffney DK (2011). Vagina. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 385-402). Philadelphia: Lippencott WIlliams and Wilkins.
Conference Proceedings
Case Report
Editorial
- Hutten RJ, Huang YJ, Gaffney DK (2021). Stereotactic body radiotherapy for the treatment of gynecologic malignancies: Passing fancy or here to stay? Gynecol Oncol, 161(3), 642-644.
- David Gaffney (Aug 2012). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? Journal of Gynecologic Oncology, 23(4), 207-210.